A Market for Sitting on the Sidelines
There may be some short-term trades and perhaps a few buying opportunities of unfairly hit stocks, but it just isn't the time to be active.
Griffon Corp.: Under-loved, Under-followed, Ready to Rumble
The maker of building products appears significantly undervalued based on its results and earnings prospects; here's how to play it.
Naspers to Unlock Its Own Value By Selling Down $129B Tencent Stake
Naspers and its investment-holding company Prosus will sell down their Tencent stake and buy their own shares, with both companies trading at big discounts to NAV.
Welcome to the Wild, Wild Market
The end of the quarter brings crazy moves, but can they be blamed for Tuesday's decline? Let's see and let's see why I think we can rally again before the quarter's over.
Hopeful Investors Get Scraped by the Bear
Bulls hoped that a bottom had been found, but they overlooked the reasons behind the rally last week.
Is It Time to Ante Up in Chip Stocks?
While it is difficult to call a bottom in any technology sector, it is hard to find an area that has better long-term growth prospects than semiconductors.
Bed Bath & Beyond's Weakness Is Likely to Persist
The shares have been in the single digits since early May.
Let's Look Under the 'Shell' of This ESG-Style Fund
One of the Nuveen Global Net-Zero Transition exchange-traded fund's largest holdings is Shell, so let's drill down on this supposedly environmentally friendly ETF.
Taking Another Look at ON Semiconductor's Charts
Here's what to watch for.
Feeling Queasy Over Moderna's Outlook? Investors May Still Get Their Shot
With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.